Hypothyroidism as an Independent Predictor of 30-day Readmission in Head and Neck Cancer Patients
© 2023 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc..
OBJECTIVES: To define the role of hypothyroidism and other risk factors for unplanned readmissions after surgery for head and neck cancer.
STUDY DESIGN: Retrospective cohort study.
METHODS: The Nationwide Readmission Database (NRD) was used to identify patients who underwent surgery for mucosal head and neck cancer (oral cavity, oropharynx, larynx, and hypopharynx) between 2010 and 2017. Univariate and multivariate logistic regression were performed to determine patient, tumor, and hospital related risk factors for 30-day readmission. Readmitted patients were stratified by preoperative diagnosis of hypothyroidism to compare readmission characteristics.
RESULTS: For the 131,013 patients who met inclusion criteria, the readmission rate was 15.9%. Overall, 11.91% of patients had a preoperative diagnosis of hypothyroidism. After controlling for other variables, patients with a preoperative diagnosis of hypothyroidism had 12.2% higher odds of readmission compared to those without hypothyroidism (OR: 1.12, 1.03-1.22, p = 0.008). Patients with hypothyroidism had different reasons for readmission, including higher rates of wound dehiscence, fistula, infection, and electrolyte imbalance. Among readmitted patients, the length of stay for index admission (mean 10.5 days vs. 9.2 days, p < 0.001), readmission (mean 7.0 vs. 6.6 days, p = 0.05), and total hospital charge were higher for hypothyroid patients ($137,742 vs. $119,831, p < 0.001).
CONCLUSION: Hypothyroidism is an independent risk factor for 30-day readmission following head and neck cancer resection. Furthermore, hypothyroid patients are more likely to be readmitted for wound complications, infection, and electrolyte imbalance. Targeted interventions should be considered for hypothyroid patients to decrease readmission rates and associated patient morbidity, potentially leading to earlier initiation of adjuvant treatment.
LEVEL OF EVIDENCE: 3 Laryngoscope, 133:2988-2998, 2023.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:133 |
|---|---|
| Enthalten in: |
The Laryngoscope - 133(2023), 11 vom: 19. Nov., Seite 2988-2998 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nyirjesy, Sarah C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Electrolytes |
|---|
| Anmerkungen: |
Date Completed 23.10.2023 Date Revised 24.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/lary.30675 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354799762 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354799762 | ||
| 003 | DE-627 | ||
| 005 | 20231226063008.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/lary.30675 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1182.xml |
| 035 | |a (DE-627)NLM354799762 | ||
| 035 | |a (NLM)36974971 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nyirjesy, Sarah C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hypothyroidism as an Independent Predictor of 30-day Readmission in Head and Neck Cancer Patients |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2023 | ||
| 500 | |a Date Revised 24.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc. | ||
| 520 | |a OBJECTIVES: To define the role of hypothyroidism and other risk factors for unplanned readmissions after surgery for head and neck cancer | ||
| 520 | |a STUDY DESIGN: Retrospective cohort study | ||
| 520 | |a METHODS: The Nationwide Readmission Database (NRD) was used to identify patients who underwent surgery for mucosal head and neck cancer (oral cavity, oropharynx, larynx, and hypopharynx) between 2010 and 2017. Univariate and multivariate logistic regression were performed to determine patient, tumor, and hospital related risk factors for 30-day readmission. Readmitted patients were stratified by preoperative diagnosis of hypothyroidism to compare readmission characteristics | ||
| 520 | |a RESULTS: For the 131,013 patients who met inclusion criteria, the readmission rate was 15.9%. Overall, 11.91% of patients had a preoperative diagnosis of hypothyroidism. After controlling for other variables, patients with a preoperative diagnosis of hypothyroidism had 12.2% higher odds of readmission compared to those without hypothyroidism (OR: 1.12, 1.03-1.22, p = 0.008). Patients with hypothyroidism had different reasons for readmission, including higher rates of wound dehiscence, fistula, infection, and electrolyte imbalance. Among readmitted patients, the length of stay for index admission (mean 10.5 days vs. 9.2 days, p < 0.001), readmission (mean 7.0 vs. 6.6 days, p = 0.05), and total hospital charge were higher for hypothyroid patients ($137,742 vs. $119,831, p < 0.001) | ||
| 520 | |a CONCLUSION: Hypothyroidism is an independent risk factor for 30-day readmission following head and neck cancer resection. Furthermore, hypothyroid patients are more likely to be readmitted for wound complications, infection, and electrolyte imbalance. Targeted interventions should be considered for hypothyroid patients to decrease readmission rates and associated patient morbidity, potentially leading to earlier initiation of adjuvant treatment | ||
| 520 | |a LEVEL OF EVIDENCE: 3 Laryngoscope, 133:2988-2998, 2023 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a head and neck cancer | |
| 650 | 4 | |a hypothyroidism | |
| 650 | 4 | |a readmissions | |
| 650 | 4 | |a surgical outcomes | |
| 650 | 7 | |a Electrolytes |2 NLM | |
| 700 | 1 | |a Zhao, Songzhu |e verfasserin |4 aut | |
| 700 | 1 | |a Judd, Ryan |e verfasserin |4 aut | |
| 700 | 1 | |a McCrary, Hilary |e verfasserin |4 aut | |
| 700 | 1 | |a Kuhar, Hannah N |e verfasserin |4 aut | |
| 700 | 1 | |a Farlow, Janice L |e verfasserin |4 aut | |
| 700 | 1 | |a Seim, Nolan B |e verfasserin |4 aut | |
| 700 | 1 | |a Rocco, James W |e verfasserin |4 aut | |
| 700 | 1 | |a Kang, Stephen Y |e verfasserin |4 aut | |
| 700 | 1 | |a Haring, Catherine T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Laryngoscope |d 1945 |g 133(2023), 11 vom: 19. Nov., Seite 2988-2998 |w (DE-627)NLM000205370 |x 1531-4995 |7 nnns |
| 773 | 1 | 8 | |g volume:133 |g year:2023 |g number:11 |g day:19 |g month:11 |g pages:2988-2998 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/lary.30675 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 133 |j 2023 |e 11 |b 19 |c 11 |h 2988-2998 | ||